Zhongchao Business Summary

Zhongchao Inc. (ZCMD) is a China-based healthcare information and technology provider that generates revenue through two primary segments: MDMOOC Services and the Sales of Patented Drugs. The company’s MDMOOC platform facilitates specialized medical training, academic conferences, and patient-aid projects, monetizing these offerings through service fees from healthcare professionals and pharmaceutical enterprises. Following a recent 18.4% year-over-year revenue contraction to approximately $15.9 million, the firm is currently executing a significant strategic realignment, which included a 1-for-8 reverse share split effective March 2, 2026, to maintain its Nasdaq listing. Within the competitive landscape, Zhongchao contends with regional peers such as Jianzhi Century Technology Group (JZ), Hello Group Inc. (MOMO), and E-Home Household Service Holdings (EJH), positioning itself as a niche specialist in medical continuing education and pharmaceutical distribution. The leadership is anchored by founder Weiguang "James" Yang, who serves as Chairman, President, and CEO, and Pei Xu, who holds the roles of Chief Financial Officer and Director. The executive suite recently underwent a major transition when Chief Medical Officer Xuejun Chen, Chief Sales Officer Baoqian Tian, and Chief Operating Officer Shuang Wu resigned simultaneously on March 15, 2026, as part of an organizational pivot toward new business strategies. This C-suite exodus leaves Yang and Xu to manage the company's operational restructuring and resource reallocation. Despite the leadership turnover, Zhongchao retains institutional backing from notable investors including Citadel Advisors LLC, Susquehanna International Group, and Two Sigma Securities, with board oversight provided by independent directors such as Dan Li and John General.